NEFL and COVID-19: Similarly, COVID-19 has been associated with increased levels neuronal injury serum markers like neurofilament light chain (NfL), neuron-specific enolase (35–37) while biomarkers like NfL, Glial fibrillary acidic protein, and tau were significantly increased in patients with fatal outcome (38).